Vimarsana
Biggest News Aggregation in the World

Page 24 - Ancer Immunotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Immunotherapy Today - Breaking & Trending Today

Machine learning models help forecast immunotherapy response from gut microbiomes - Vimarsana News

Machine learning models help forecast immunotherapy response from gut microbiomes

A new research paper was published in Oncotarget on July 19, 2022, entitled, "Predicting cancer immunotherapy response from gut microbiomes using machine learning models."

Cytokine-based cancer immunotherapy: Current progress and future prospects - Vimarsana News

Cytokine-based cancer immunotherapy: Current progress and future prospects

In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects.

Bacterial species known for causing diarrheal infections may also drive colorectal cancer - Vimarsana News

Bacterial species known for causing diarrheal infections may also drive colorectal cancer

Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.

Amgen joins Kernal Bio's $25M financing as the startup brings mRNA 2.0 to cancer - Vimarsana News

Amgen joins Kernal Bio's $25M financing as the startup brings mRNA 2.0 to cancer

Kernal Biologics has technology that enables the delivery of messenger RNA therapies to a wider range of destinations in the body. The Series A financing comes as the startup works to advance its lead immuno-oncology program toward its first clinical test.

Whole exome sequencing predicts whether patients respond to cancer immunotherapy - Vimarsana News

Whole exome sequencing predicts whether patients respond to cancer immunotherapy

Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers.